Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...His mother was a Time Inc executive, and his father a Washington diplomat who worked for the US Agency for International Development....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...To give you a sense of how desperate companies are to secure new assets you just need to remember how Sanofi started a bidding war for Medivation, only to lose out to Pfizer in August 2016, and how it later...
...were down about $250m after a 17 per cent plunge in Allergan shares, his largest holding, on April 5 following news that tough tax rules from the Obama administration had scuppered a takeover bid from Pfizer...
...Pfizer’s $160bn takeover of Allergan was due to be finalised in the second half of this year....
...losses for some hedge funds, such as Paulson & Co and Third Point....
...He also said he had support from other big investors, including hedge fund manager John Paulson....
...A spokesperson for Paulson, which holds almost five per cent of Shire’s shares, said: “We believe this transaction creates enormous value for AbbVie shareholders....
...Potts, a leading company law advocate, drew attention to the famous case of Carlill v Carbolic Smoke Ball Company....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...Shire’s share price dropped 11 per cent on the day the deal fell through, catching hedge funds with large exposure to the company, such as Paulson & Co, off guard....
...John Paulson, whose fund owns almost 5 per cent of Shire, faced a paper loss of more than £300m....
...Buffett’s Berkshire Hathaway Inc. BRKB -0.92% also trimmed its holdings in General Motors Co. in the first quarter, securities filings show....
...Paulson is shorting Bunds: the hedge fund manager told investors he saw eurozone problems worsening significantly, says the FT....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Approximately one month after the ACA and IKB note purchases in April 2007, ABN AMRO N.V. (“ABN,” now owned by RBS) entered into a swap transaction referencing the ABACUS 2007-AC1 portfolio....
...As the Court’s argument continued in TSC Industries, Inc. v....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Merck fell 0.9 per cent to $37.34 and Pfizer lost 0.3 per cent to $17.67....
...- Paulson takes another bite of Cadbury. - Steelie Neelie squares up to Silvio. Over in the Long Room, - On Russian politics & reform. - Mr V and Mr O review Hix, Brewer Street, Soho....
...He points to Treasury Secretary Hank Paulson’s statement on Sunday morning television shortly after the rescue, saying the purpose was to “allow the government to liquidate” the company....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
International Edition